Stryker said reported net sales for the quarter ended Q1 2026 increased 2.6% to $6.0 billion, and organic net sales increased 2.4%, of which 2.1% was from increased unit volume and 0.3% was from higher prices.

1. 01

   Stryker said reported net sales for the quarter ended Q1 2026 increased 2.6% to $6.0 billion, and organic net sales increased 2.4%, of which 2.1% was from increased unit volume and 0.3% was from higher prices.

2. 02

   The company said reported net earnings for the quarter ended Q1 were $745 million, an increase of 13.9%, and reported diluted earnings per share were $1.93. Adjusted diluted earnings per share were $2.60, a decrease of 8.5%, and adjusted operating income margin contracted 180 basis points to 21.1%.

3. 03

   Stryker disclosed that net cash provided by operating activities for the 3 months of 2026 was $581 million, compared with $250 million in the prior year period, and that cash and cash equivalents decreased from $4,011 million to $2,878 million due to net debt repayments of $1,000 million and dividend payments of $337 million.

4. 04

   Stryker said it is maintaining its full year 2026 guidance of organic net sales growth in the range of 8.0% to 9.5% and adjusted diluted earnings per share in the range of $14.90 to $15.10. It added that should foreign exchange rates hold near current levels, both sales and adjusted earnings per share are expected to have a slightly favorable impact.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.